Clinical Trial Update: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Plitidepsin versus control in moderate COVID-19 infection was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection

Drugs mentioned

• Plitidepsin (plitidepsin)

Snippet

Sponsor: PharmaMar | Conditions: COVID-19 Infection | Phase 3 | Status: TERMINATED | Results posted: 2025-02-21